This site is intended for healthcare professionals only
News
Share this article

Incretin-based diabetes therapies: An updated statement from the PCDS Committee

The PCDS Committee has published an updated version of its statement in the latest issue of Diabetes & Primary Care (vol 15 no 4).

The PCDS Committee has published an updated version of its statement in the latest issue of Diabetes & Primary Care (vol 15 no 4). You can access it via the link below (you will need to register for the site to access the content, if you have not already done so).

Click here for access to updated statement

Related content
Prevention of diabetic maculopathy: Trial of oral medication begins
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.